Luye Pharma Group Ltd, a Chinese pharma company listed on the Mainboard of the Hong Kong Stock Exchange, has completed its acquisition of the transdermal drug delivery systems (TDS) business from Swiss company, Acino.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
